Hematology NewsGetting hematologic cancer drugs on the fast trackFebruary 9, 2018T Cell LymphomasAggressive Lymphomas
Hematology NewsT-cell lymphoma therapies on the horizonFebruary 9, 2018T Cell LymphomasAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology TimesDrug may be option for B- and T-cell lymphomasFebruary 9, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesAssay identifies actionable mutations in lymphoid malignanciesFebruary 9, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsDecline in non-Hodgkin lymphoma deaths to continue in 2018February 7, 2018Aggressive LymphomasPractice ManagementBusiness of Medicine
Hematology TimesCombo is preferentially active in T-cell lymphomasFebruary 7, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology NewsTRANSCEND NHL trial identifies window for CAR T expansionFebruary 6, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesIn situ vaccination eradicates lymphoma, other cancersFebruary 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCombo could treat double-hit lymphomaFebruary 2, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeCheckpoint inhibitors look safe in rheumatology patientsJanuary 24, 2018Immuno-oncologyCellular TherapyAggressive Lymphomas
Hematology TimesRisks of MGUS persist beyond 30 yearsJanuary 18, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCAR T-cell therapy on fast track in US, EUJanuary 18, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Oncology PracticeFDA grants priority review to CAR T-cell therapy for DLBCLJanuary 17, 2018Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology TimesGeneric bortezomib available in USJanuary 13, 2018Lymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology NewsAUDIO: Immunotherapy’s role in NHLJanuary 11, 2018Aggressive LymphomasIndolent Lymphoma
